BioVenture
116
15M
101
10.55
28
0.11
3
- Stages of investment
- Areas of investment
Summary
BioVenture appeared to be the VC, which was created in 2013. The main department of described VC is located in the Suzhou. The fund was located in Asia if to be more exact in China.
Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this BioVenture works on 24 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2018. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.
The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight inui Health, LAM Therapeutics, Innovita Biological Technology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Health Diagnostics, Therapeutics.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the BioVenture, startups are often financed by Yueyin Venture Capital, Proxima Ventures Ltd, Luc De Vos. The meaningful sponsors for the fund in investment in the same round are OrbiMed, CD Capital, iGlobe Partners. In the next rounds fund is usually obtained by YuanMing Capital, Sanofi, Qiming Venture Partners.
This organization was formed by Jacky Chen.
Investments analytics
Analytics
- Total investments
- 116
- Lead investments
- 28
- Exits
- 3
- Rounds per year
- 10.55
- Follow on index
- 0.11
- Investments by industry
- Health Care (57)
- Medical (43)
- Biotechnology (37)
- Pharmaceutical (17)
- Medical Device (15) Show 51 more
- Investments by region
-
- China (99)
- United States (8)
- Taiwan (1)
- Germany (1)
- Peak activity year
- 2021
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 14M
- Group Appearance index
- 0.70
- Avg. company exit year
- 9
- Avg. multiplicator
- 0.16
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| RainSure Scientific | 25 Sep 2019 | Early Stage Venture | 1M | Jiangsu, Suzhou, China | |
| Smartee | 01 Jan 2017 | Early Stage Venture | Shanghai, Shanghai, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.